Biomea Fusion Stock Climbs 7% After-Hours: What's Going On?

Biomea Fusion, Inc. (NASDAQ: BMEA) shares increased by 6.61% to $1.45 in after-hours trading following the announcement that the company will report Phase I results for its oral GLP-1 candidate BMF-650 on October 13. The company has a market capitalization of approximately $98.58 million, and over the past year, its stock has traded between a high of $2.24 and a low of $0.87, with a 12-month decline of 17.58%. Prior to the after-hours increase, shares fell 4.23% to close at $1.36 on Monday.